View in EDS

Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc.: United States Court of Appeals of the Federal Circuit, 2025 130 F.4th 1363.

Saved in:
Bibliographic Details
Title: Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc.: United States Court of Appeals of the Federal Circuit, 2025 130 F.4th 1363.
Authors: Holman, Christopher M.1 (AUTHOR)
Source: Biotechnology Law Report. Jun2025, Vol. 44 Issue 3, p200-204. 5p.
Database: Business Source Ultimate
Description
ISSN:0730031X
DOI:10.1089/blr.2025.80803.mer